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Abstract
Because of its low relative folding rate and plentiful manufacture in b-cells, proinsulin maintains a homeostatic balance of
natively and plentiful non-natively folded states (i.e., proinsulin homeostasis, PIHO) through the integration of maturation
and disposal processes. PIHO is susceptible to genetic and environmental influences, and its disorder has been critically
linked to defects in b-cells in diabetes. To explore this hypothesis, we performed polymerase chain reaction (PCR),
metabolic-labeling, immunoblotting, and histological studies to clarify what defects result from primary disorder of PIHO in
model Ins2
+/Akita b-cells. We used T antigen-transformed Ins2
+/Akita and control Ins2
+/+ b-cells established from Akita and
wild-type littermate mice. In Ins2
+/Akita b-cells, we found no apparent defect at the transcriptional and translational levels to
contribute to reduced cellular content of insulin and its precursor and secreted insulin. Glucose response remained normal
in proinsulin biosynthesis but was impaired for insulin secretion. The size and number of mature insulin granules were
reduced, but the size/number of endoplasmic reticulum, Golgi, mitochondrion, and lysosome organelles and vacuoles were
expanded/increased. Moreover, cell death increased, and severe oxidative stress, which manifested as increased reactive
oxygen species, thioredoxin-interacting protein, and protein tyrosine nitration, occurred in Ins2
+/Akita b-cells and/or islets.
These data show the first clear evidence that primary PIHO imbalance induces severe oxidative stress and impairs glucose-
stimulated insulin release and b-cell survival as well as producing other toxic consequences. The defects disclosed/clarified
in model Ins2
+/Akita b-cells further support a role of the genetic and stress-susceptible PIHO disorder in b-cell failure and
diabetes.
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Introduction
Pancreatic b-cell failure in diabetes is characterized primarily by
progressive loss of insulin production and b-cell mass. b-cell failure
has been attributed to autoimmune assault in type 1 diabetes and
to glucolipotoxicity, amyloid deposition, insulin resistance, and
endoplasmic reticulum (ER) and/or oxidative stress in type 2
diabetes [1–10]. However, the intrinsic mechanisms underlying b-
cell susceptibility to stress and damage remains largely unclear.
Are b-cells overwhelmed by such stress and its associated toxic
byproducts, such as reactive oxygen species (ROS), or does the
attenuation of beneficial genes and/or trigger of harmful genes
prove detrimental to some inherent property specific to cell type?
Data exist to support both views, but b-cell dysfunction and
damage resulting from various stress insults, such as from
hypoglycemia/hypoxia [11,12] and chronic hyperglycemic and
hyperlipidemic conditions [2–10,13–15], in addition to influences
by genetic variations support the second view. As well, low
expression levels of genes protective against oxidative stress or
hypoglycemia/hypoxia insult, such as catalase or hypoglycemia/
hypoxia inducible mitochondrial protein 1, are implicated in the
susceptibility of b-cells to stress [16,17].
Moreover, as b-cells mature to produce insulin, they become
sensitive to cytokine insult [18]. Insulin is the most abundant and
unique protein produced in b-cells and constitutes up to 14% of
the dry weight of rodent islets or b-cells [19,20]. Studies of protein
biosynthesis in rodent/carp islets have shown incorporation of 6 to
30% of radioactive amino acids into preproinsulin in basal or
glucose-stimulated conditions [21,22], although many proteins are
produced in islets/b-cells. Proinsulin is the precursor of most
abundant insulin in the ER, preserves a low relative folding rate,
and bears the greatest burden in the protein folding of b-cells [23].
Thus, it maintains a homeostatic balance of natively and plentiful
non-natively folded states (i.e., proinsulin homeostasis, PIHO) in
b-cells as a result of the integration of maturation and disposal
processes for adaptation [23]. Both the substrate-favored lysosom-
al and proteasomal pathways participate in the normal mainte-
nance of PIHO in b-cells [24]. The contrast of low relative folding
rate with plentiful amounts of insulin precursor manufactured in
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influences, such as changes in cellular energy and Ca
2+,E Ro r
oxidative stress, and cytokine insults [23,24]. PIHO disorders have
been found in Ins2
+/Akita [23], non-obese diabetic (NOD), and db/
db mice (unpublished data), unique models that represent the
primary forms of diabetes in humans. Monogenic disorders
include syndromes characterized in early studies that resemble
type 2 diabetes caused by mutations in the insulin gene in non-
neonatal patients [25]. Recently, up to 20% of human neonatal
diabetes with proband variants for type 1, and even type 2, has
been associated with defective insulin genes and demonstrated
pathogenesis resembling that in the Ins2
+/Akita mouse model [26–
29]. Those subjects with defects in the same preproinsulin
molecule showed b-cell failure resembling that in general diabetes.
Therefore, we have suggested that disorder in PIHO is critically
linked to b-cell failure and diabetes [23].
To test this hypothesis, we further characterized defects that
resulted from primary PIHO in Ins2
+/Akita b-cells derived from the
diabetic Akita mouse [30]. In the Akita mouse model, diabetes
occurs early, at age 4 weeks, as a result of primary PIHO disorder
induced by a point mutation (Ins2
+/Akita, C96Y) in an allele of the
insulin 2 gene [23,31]. Because it is difficult to achieve sufficient
numbers of b-cells/islets from diabetic Ins2
+/Akita mice for study,
we evaluated PIHO disorders and their consequences using T
antigen-transformed Ins2
+/Akita and control Ins2
+/+ b-cells estab-
lished from Akita and wild-type littermate mice [30]. Similar
findings of disorders in PIHO, subsequent proinsulin conversion,
and enhanced response to ER stress between the established Ins2
+/
Akita b-cell lines and the islets of Ins2
+/Akita mice [23,30–32]
demonstrate the utility of Ins2
+/Akita and control Ins2
+/+ b-cell lines
for such study. However, other typical defects of b-cells with
known association to diabetes of general forms remain unchar-
acterized in this model of b-cell dysfunction; these include
oxidative stress and abnormalities in glucose-stimulated insulin
secretion (GSIS) and b-cell survival. Unlike islets exposed to in vivo
hyperglycemic or euglycemic environments in diabetic or non-
diabetic subjects, the Ins2
+/Akita and Ins2
+/+b-cell lines remain in
the customary culture condition (with 25.5 mmol/L glucose) in
which they are established [30] and are therefore ideal models for
testing our hypothesis. In this follow-up study using the
dysfunctional Ins2
+/Akita b-cell model, we further disclose/clarify
the toxic consequences of PIHO disorder that are generally
associated with diabetes.
Results
No apparent transcriptional and translational defect
contributes to the reduced proinsulin and insulin content
of Ins2
+/Akita b-cells
In model Ins2
+/Akita b-cells/islets, the consistent reduction in
proinsulin and insulin content and secreted insulin has been
attributed to defects in transcriptional [30], translational [7], or
post-translational [31,33] regulation in addition to b-cell deple-
tion. To clarify the reason for this reduction, we performed studies
in the established Ins2
+/Akita and Ins2
+/+b-cells cultured under the
customary high (25. 5 mmol/L) glucose condition. In light
microscopic images (with 200-fold amplifications), the only
apparent difference in morphology between these 2 cell lines
was a seemingly slight hypertrophy of Ins2
+/Akita b-cells (Fig. 1A).
Using approaches described previously [17,23,31], our quantita-
tive polymerase chain reaction (PCR) and metabolic-labeling
analyses detected no decline in the transcriptional and transla-
tional levels of proinsulin in Ins2
+/Akita b-cells versus control Ins2
+/+
b-cells (Fig. 1B and 1C; transcript, 103.868.2% versus
100.066.5%;
35S-proinsulin, 109.766.3% versus 100.067.2%;
P.0.05, n=3). Neither did microarray analysis detect any
reduction in the insulin transcripts of Ins2
+/Akita b-cells (unpub-
lished observations). These findings indicate that abnormalities
responsible for the reduced insulin content in Ins2
+/Akita versus
Ins2
+/+ b-cells (Fig. 1D; 27.964.3% versus 100.068.1%; P,0.01,
n=3) and the reduced insulin secretion [17,23,31,32] occur
mainly in the regulation of post-translational processing.
Glucose response remained normal in proinsulin
biosynthesis but was impaired for insulin secretion of
Ins2
+/Akita b-cells
Impaired glucose-stimulated insulin secretion in diabetes is well
recognized, but its underlying mechanisms remain largely unclear
[34–36]. To explore the association between early PIHO disorders
and subsequent GSIS abnormalities, we examined the response in
Ins2
+/Akita and Ins2
+/+ b-cells of proinsulin biosynthesis or insulin
secretion to stimulation in a culture with high glucose concentra-
tion (25.5 mmol/L) after one-day preculturing with 5.5 mmol/L
glucose. Immunoblot analysis showed similar increases in the
amount of proinsulin in Ins2
+/Akita b-cells and control b-cells in
response to 24-hour stimulation in the high glucose environment
(Fig. 2A, 50.567.3% versus 54.3611.1%; P.0.05, n=3), findings
suggesting that there was no apparent defect in the regulation of
proinsulin transcriptional and translational responses to glucose.
However, following either a 15- or 120-minute course of glucose
stimulation, the amount of insulin secreted by Ins2
+/Akita b-cells was
reduced compared with that of control Ins2
+/+ b-cells (Fig. 2B;
15 minutes, 53.5612.7% versus 100.0616.0%; 120 minutes,
58.8627.8% versus 100.0636.0%; P,0.05, n=3). The release
of insulin during the 15- or 120-minute course of glucose
stimulation mimicked that in the first or second phase of GSIS
by islets in vivo. These results demonstrate the impairment of GSIS
in Ins2
+/Akita b-cells as a result of PIHO disorder. Moreover, the
finding of an abnormally high ratio of proinsulin/insulin in the
secreted proinsulin and insulin from Ins2
+/Akita b-cells (Fig. 2B) was
consistent with our recently reported findings [32].
As shown in Fig. 2B, our immunoprecipitation approach with
mixed antisera to C-peptide and insulin pulled down large
amounts of secreted proinsulin and insulin from culture media.
Immunoblot analysis of these secreted proinsulin and insulin
allowed us to find the above described impairments in the insulin
secretion of Ins2
+/Akita b-cells versus control Ins2
+/+ b-cells. Our
immunoprecipitation approach with mixed antisera to C-peptide
and insulin showed an advantage in recovery of proinsulin
compared to the immunoprecipitation approach customarily using
insulin antisera alone (Fig. S1). These outcomes clearly demon-
strated that the immunoprecipitation combined with the immu-
noblot approach that we used in this study and reported previously
[32] is a reliable procedure in addition to the traditional
radioimmunoassay approach in evaluation of GSIS and its
impairments. Furthermore, this method can evaluate the propor-
tional composition of secreted insulin and proinsulin when insulin
in secreted proteins is measured at the same time. This is because
proinsulin as a component of insulin immunoreactive materials,
which cannot be well distinguished or determined by radioimmu-
noassay using insulin antibody alone, was indeed detected and
distinguished by using the immunoprecipitation combined with
the immunoblot method shown in our study.
Structural abnormalities of Ins2
+/Akita b-cells
To verify the structural abnormalities preserved in the
established Ins2
+/Akita b-cells under in vitro culture maintenance,
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controls, Ins2
+/Akita b-cells demonstrated reduced numbers and size
of mature insulin granules; enlarged ER, Golgi, and mitochon-
drion organelles; and increased numbers of lysosomes and
vacuoles (Fig. 3; P,0.01, n=10; see Table S1 for details).
Intriguingly, a number of structures resembling bean pods
appeared specifically in Ins2
+/Akita b-cells that seemed to represent
small atypically interacting insulin granules, but further investiga-
tion is required to clarify their nature. Because the Ins2
+/Akita and
Ins2
+/+ b-cells have been maintained at 25.5 mmol/L glucose
Figure 1. No apparent transcriptional and translational defect contributes to the reduced proinsulin and insulin content of Ins2
+/Akita
b-cells. (A) Light microscopic images (with 200-fold amplifications) of Ins2
+/Akita and Ins2
+/+ b-cells cultured for 48 hours under customary condition
(containing 25. 5 mmol/L glucose). (B) We examined the levels of insulin transcripts in Ins2
+/Akita and control Ins2
+/+b-cells using quantitative PCR
approaches described in Materials and Methods. (C) Newly synthesized
35S-proinsulin or
35S- tubulin in Ins2
+/Akita or Ins2
+/+b-cells during a 30-minute
labeling course was immunopurified with C-peptide or tubulin antisera and dissolved by reduced SDS-PAGE for autoradiography. (D) We used
immunoblot analysis to evaluate the levels of immunoreactive proinsulin and insulin of Ins2
+/Akita and Ins2
+/+b-cells cultured for 48 hours under
customary condition. Data shown in (A to D) represent 3 independent experiments.
doi:10.1371/journal.pone.0035098.g001
Figure 2. Glucose response remained normal in proinsulin biosynthesis but was impaired for insulin secretion of Ins2
+/Akita b-cells.
(A) We examined the levels of proinsulin in Ins2
+/Akita and Ins2
+/+ b-cells cultured for 24 hours at 5.5 or 25.5 mmol/L glucose conditions by C-peptide
immunoblot. (B) Proinsulin and insulin secreted by Ins2
+/Akita or Ins2
+/+ b-cells during a 15- or 120-minute course of glucose stimulation were
immunopurified with insulin and C-peptide antisera, resolved by 16.5% tricine non-reduced SDS-PAGE, and examined by insulin immunoblot. Data
shown in (A and B) represent 3 independent experiments.
doi:10.1371/journal.pone.0035098.g002
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alterations evident in Ins2
+/Akita b-cells and not control Ins2
+/+ b-
cells clearly indicate that they are indeed toxic consequences of a
primary PIHO disorder and do not result primarily from
glucotoxicity in vivo.
Severe oxidative stress in Ins2
+/Akita b-cells/islets
Accumulating data indicate that the oxidative folding process of
proteins in the ER generates ROS, and suboptimal folding
conditions could increase ROS production [7]. We applied a
number of oxidative stress markers to examine whether disorder in
PIHO produces an increase in ROS in the established Ins2
+/Akita
b-cells and/or Akita islets. As shown in Figure 4A, the
immunoreactive level of thioredoxin-interacting protein (TXNIP),
a regulator of the cellular redox state [37], increased in both
primary and established Ins2
+/Akita b-cells. Likewise, the fluorescent
signal of 29,79-dichlorodihydrofluorescein diacetate (H2DCFDA),
a widely used reliable fluorogenic marker for ROS in live cells,
increased significantly in the Ins2
+/Akita b-cells compared to
controls (Fig. 4B and C; fold, 1.860.9 versus 1.060.4; P,0.005,
n=5). We also examined the level of protein tyrosine nitration
(Tyr-N) in Ins2
+/Akita b-cells. In living cells, protein Tyr-N is
generally mediated by ROS, such as peroxynitrite anion and
nitrogen dioxide. Immunoblot analysis exposed an increase in the
levels of Tyr-N proteins in Ins2
+/Akita b-cells (Fig. 5A), which was
more apparent in the nucleus protein pool (Fig. 5B). In histological
studies, Tyr-N protein immunoreactivity was predominant in the
nuclei of the b-cells of 12-week-old Ins2
+/Akita islets and higher than
in control b-cells of 12-week-old Ins2
+/+islets (Fig. 5C and D; fold,
2.060.2 versus 1.060.3; P,0.005, n=15). These findings clearly
demonstrate the occurrence of severe oxidative stress in both
primary and cloned Ins2
+/Akita b-cells.
Altered death and proliferation rates of Ins2
+/Akita b-cells
To clarify whether PIHO disorder alters the rates of death and
proliferation of b-cells, we compared these rates in Ins2
+/Akita and
Ins2
+/+b-cells. The rates were assessed by the number/percentage
of alive and dead cells during culture periods that was determined
by trypan blue staining procedure. This procedure that detects
dead cells via apoptotic and/or necrotic pathways is described in
the Materials and Methods and Figure 6 legend. At 24, 48, 72, and
96 hours after we seeded cells (on 6-well plates) for culture under
the customary condition, we observed a significant increase in the
number of detached Ins2
+/Akita b-cells only at 96 hours (Fig. 6A,
P,0.01, n=6). Staining with trypan blue dye indicated that all
detached cells were dead (not shown), which suggests that the
detached dead Ins2
+/Akita b-cells did not increase until the end of
the 4-day observation period. However, the numbers of Ins2
+/Akita
b-cells attached (on culture plates) or attached and detached (total
number) decreased significantly (P,0.05, n=6) at each examina-
tion time-point from the beginning (Fig. 6B and D). The decrease
in the total number of Ins2
+/Akita b-cells at the individual
examination time-points resulted partially from an increase in
Figure 3. Structural abnormalities of Ins2
+/Akita b-cells. We
examined the subcellular structure of Ins2
+/+ (A and C) and Ins2
+/Akita
(B and D) b-cells after 48-hour customary culture by electric microscopy
as described in the Materials and Methods. Asterisk, bean pod-like
structure (that may represent atypically interacting forms of small
insulin granules); Gr, mature insulin granules; white arrow, mitochon-
dria; black arrow, lysosomes; 5-point star, enlarged endoplasmic
reticulum (ER)/Golgi compartments or vacuoles; scale bar, 1 mmi n( A
and B) or 2 mm in (C and D). We performed quantitative evaluation of
photographs from 10 b-cells for each group as described previously
[42], and Table S1 presents the detailed data.
doi:10.1371/journal.pone.0035098.g003
Figure 4. TXNIP and ROS increased in Ins2
+/Akita b-cells/islets. (A)
WeperformedimmunoblotanalysisofthelevelsofTXNIPintheIns2
+/Akita
andIns2
+/+ b-cellsorislets(at 12weeks ofage).Proteinamount per lanein
(A), 40 mg. Fluorescent signals (C) and levels (B) of 29,79-dichlorodihydro-
fluorescein diacetate (H2DCFDA) fluorogenic marker (for ROS) in the
established Ins2
+/Akita and Ins2
+/+b-cells. Scale bar in (C), 100 mm. Data are
presented as the mean 6 standard deviation (SD). n=5; **, P,0.005.
doi:10.1371/journal.pone.0035098.g004
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attached) compared to the proportion in control Ins2
+/+ b-cells
(Fig. 6C; 24 hours, 4.160.5 versus 2.660.4; P,0.0001; 48 hours,
4.560.6 versus 3.760.4, P,0.05; 72 hours, 7.760.6 versus
5.361.9, P,0.05; 96 hours, 13.863.3 versus 6.360.5, P,0.001;
n=6).
Based on the total numbers of cells examined at the individual
time-points, we obtained 2 reliable formulas to estimate the times
required for Ins2
+/+ or Ins2
+/Akita b-cells to double their numbers
under customary culture conditions (Fig. 6E, see detailed
explanations in the figure legend). The times required to double
the number of Ins2
+/Akita b-cells increased 38.1 to 42.8% compared
with the doubling time of control Ins2
+/+ b-cells (Fig. 6F). The less
than 3% difference between percentages of dead cells in these 2 b-
cell lines (with the same passage numbers) at all time-points except
96 hours (Fig. 6C) cannot fully explain this 4.7% increase in the
hours required for a cycle of cells to double in number. These
results suggest that decelerated proliferation of Ins2
+/Akita b-cells
may contribute to the large differences between the total numbers
of cells in these 2 b-cell lines at examination time-points (Fig. 6D).
This proposition was proven true because Ins2
+/Akita b-cells have
slower proliferation rates than control Ins2
+/+b-cells in 59-bromo-
29-deoxyuridine (BrdU) labeling assays (Fig. S2, P,0.005; n=3).
Discussion
To understand better the defects that result from a primary
PIHO disorder, we further investigated model Ins2
+/Akita b-cells/
islets. First, quantitative PCR, metabolic-labeling, and immuno-
blotting studies (Fig. 1) showed no apparent defect in the
contribution by proinsulin transcription or translation to the
reduction of cellular proinsulin and insulin in Ins2
+/Akita b-cells.
Because we maintained Ins2
+/Akita and Ins2
+/+ b-cells under the
same culture conditions, our results excluded contributions from
possible differences in glucose effect and/or b-cell population that
sometimes appear in studies using islets of diabetic versus normal
subjects. These data thus supported the primary responsibility of
abnormalities in the early post-translational processing of insulin
precursor for reduced proinsulin and insulin content and secreted
insulin in Akita mice [31–33]. They do not support the
enhancement of eukaryotic initiation factor 2 (eIF2a) phosphor-
ylation for translational attenuation [7] as the principal protective
mechanism in b-cells with PIHO disorders, although this pathway
is active in many dysfunctional cell types. The reason is that no
noticeable attenuation of proinsulin or whole protein biosynthesis
was found in primary and cloned Ins2
+/Akita b-cells (Fig. 1C) [30–
33]. Moreover, excessive eIF2a phosphorylation is poorly
Figure 5. Protein tyrosine nitration (Tyr-N) enhanced in Ins2
+/Akita b-cells/islets. We performed immunoblot analysis of the Tyr-N proteins in
the protein pool of the entire cell (A) or its nucleus (B) of Ins2
+/Akita and Ins2
+/+ b-cells. Amount of protein per lane in (A) or (B), 40 mg. C: We performed
fluorescent staining to examine the immunoreactivities of Tyr-N protein (red color) in the b-cells that were marked with C-peptide (Cp)
immunoreactivities (green color) and located within Ins2
+/Akita (lower panels) or Ins2
+/+ (upper panels) islets at 12 weeks of age. Nuclei were marked
by DAPI staining. D: The results show the nuclear abundance of Tyr-N proteins in the b-cells of Ins2
+/Akita or Ins2
+/+ islets that were determined by
using ImageJ software. Data in (D) are presented as the mean 6 standard deviation (SD). n=15; **, P,0.005.
doi:10.1371/journal.pone.0035098.g005
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fatty acids [38].
Second, the immunoblot result (Fig. 2) provides the first clear
evidence of the responsibility of a primary disorder in PIHO for
impaired GSIS at 15 or 120 minutes, although the response of
proinsulin biosynthesis to glucose stimulation was customarily
maintained in Ins2
+/Akita b-cells. These results also confirmed a
recent finding of a primary PIHO disorder causing a dispropor-
tionally high ratio of proinsulin/insulin in the secreted proteins of
Ins2
+/Akita islets/b-cells [32]. Although mechanistic models for
GSIS or proinsulin conversion to insulin in normal b-cells have
been well established [35,39], the mechanisms underlying
impaired GSIS in type 1 or type 2 diabetes remain largely
unclear [34,36]. The findings shown in Figure 2 underscore a
potentially important role of PIHO disorder in the impaired GSIS
and disproportionate hyperproinsulinemia in diabetes.
Third, histological studies (Fig. 3, Table S1) disclosed that
various structural abnormalities preserved by the established
Ins2
+/Akita b-cells, including reduced size and number of mature
insulin granules, enlarged ER, Golgi, and mitochondrion
organelles, and increased numbers of lysosome and vacuoles,
were comparable to abnormalities observed in Akita islets
[31,33,40–42]. The data excluded the contribution from gluco-
toxicity because Ins2
+/+ b-cells did not develop such abnormalities,
although both Ins2
+/Akita and Ins2
+/+ b-cells were cultured at the
same high glucose condition from the time they were established
[30]. On the one hand, the reduced numbers and size of mature
insulin granules caused by PIHO disorders should be a basis for
the impaired GSIS of Ins2
+/Akita b-cells. On the other, PIHO
disorder would yield enlarged/increased early secretory compart-
ments, energy supply, and protein disposal apparatuses as
adaptations or consequences. Alterations, such as the lessening
(or degranulation) of mature insulin granules and expansion of
varied organelles, are frequently noticeable in animal models and
humans with diabetes induced by various factors [43–47]. The
similarity in structural abnormalities supports the suggestion that
the genetic and stress-susceptible PIHO disorder may be a general
contributor in the structural defect of b-cells in diabetes.
Fourth, although a link is recognized between ER stress (as a
consequence of misfolded proteins) and oxidative stress [7], our
investigation showed the first clear evidence that PIHO disorder
produces severe oxidative stress, manifested by a significant increase
in the ROS, TXNIP, and protein Tyr-N levels of Ins2
+/Akita
b-cells/islets (Figs. 4 and 5). It is known that oxidoreductases, such
as ER oxidoreductin 1 (ERO1) and protein disulfide isomerase
(PDI), generally drive the thiol-disulfide equilibrium toward
disulfide bond formation of proteins in the ER. PDI directly
catalyzes the disulfide bond formation in nascent proteins and
transfers electrons from thiols to ERO1. ERO1 passes the electrons
to molecular oxygen and generates ROS in the process [7]. Correct
conformation of proinsulin, which requires formation of 3
intramolecular disulfide bonds with assistance of members of the
ERO1 and PDI families, can generate ROS. Disorder in PIHO
could cause repeated unproductive cycles of proinsulin oxidation
and reduction and increased ROS production from the ER, if
sustained, result in calcium leakage from the ER lumen and uptake
into the mitochondrial matrix, which would enhance production of
ROS also in the mitochondria as that observed in other cell types
with induced ER dysfunction [48].
Intriguingly, the increase of protein Tyr-N seems to be
predominant in the nucleus of Ins2
+/Akita b-cells/islets (Fig. 5),
which suggests that the protein Tyr-N is highly active in the nuclei
of b-cells with PIHO disorders. Although no data has been
produced to date regarding how the enhanced aggregation and
disposal of proinsulin is associated with this kind of oxidative stress,
recent progress in biomedical research provides clues to our
Figure 6. Altered death and proliferation rates of Ins2
+/Akita b-cells. At the indicated time-points after Ins2
+/Akita and Ins2
+/+b-cells with the
same passage numbers were seeded on 6-well/plates (5.0610
5 cells/well) and cultured in the customary medium, we examined the number of
detached (A), attached (B), and dead Ins2
+/Akita and Ins2
+/+b-cells using the approach described in Materials and Methods. We calculated the
percentage of dead cells (C) in the total Ins2
+/Akita or Ins2
+/+b-cells at each of the indicated time points (D) using the formula: dead cell (%)=(dead cell
number)6100%/(dead cell number+alive cell number). Data in (A to D) are presented as the mean 6 standard deviation (SD). n=6. *, P,0.05; **,
P,0.005. (E) Based on the total cell numbers examined at individual time-points, we obtained 2 reliable formulas to estimate the numbers (Y) of Ins2
+/+
or Ins2
+/Akita b-cells at a given time-point (X, 24#X#96, hours). Thenearer the R-squared value (relative predictive power of a formula model) to one, the
betterthemodel.(F) We usedtheformulas in(E) tocalculatethe times (hours)requiredfor the initiallyseeded5.0610
5 Ins2
+/+ or Ins2
+/Akitab-cells/wellto
propagate up to the numbers listed in the first column. The increase (%) refers to the increased percentage in the hours required for the numbers of
Ins2
+/Akita versus Ins2
+/+ b-cells to double.
doi:10.1371/journal.pone.0035098.g006
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protein misfolding, ROS increase is observed in Ins2
+/Akita b-cells
that preserve an enhanced proinsulin aggregation and disposal as a
result of a point mutation in the Ins2 gene. Increased ROS such as
free radical superoxide and/or hydrogen peroxide may facilitate
nuclear translocation of some proteins such as the transcriptional
factor NF-kB and lead to the formation of peroxynitrite, a
molecule that is a powerful oxidant [2,6,49]. Because of its
oxidizing and membrane-penetrating properties, peroxynitrite can
damage or modify various molecules in cells, including DNA and
proteins. Tyr-N is known as a main mechanism that underlies
protein damages/modifications provoked by peroxynitrite anion
and other ROS such as nitrogen oxide. As reviewed [50], Tyr-N
occurred in proteins such as the NF-kB, ikBa, PPARc, p53, and
histones that are predominantly located in the nucleus of cells. In
Ins2
+/Akita b-cells/islets, some of these processes that would possibly
occur may contribute to the abundant nuclear localization of Tyr-
N proteins observed in this study. Furthermore, the increase of
signals of H2DCFDA and TXNIP in addition to protein Tyr-N
(Fig. 4) indicates insult of the entire cell and not just the ER
compartments by oxidative stress in Ins2
+/Akita b-cells. These
results suggest that the genetic and stress-susceptible PIHO
disorder may contribute to oxidative stress manifested as increased
ROS (e.g., hydrogen peroxide) and/or protein Tyr-N, markers
well demonstrated in dysfunctional b-cells in type 1 [1,2,51] or
type 2 diabetes [2,6,7,46,47].
Lastly, our studies provide the first demonstration that PIHO
disorder concurrently augments death and decelerates prolifera-
tion of b-cells (Figs. 6 and S2). Because we subjected Ins2
+/Akita b-
cells and control Ins2
+/+ b-cells with identical passage numbers to
the same experimental procedure under in vitro culture condition,
this data excluded the contributions from possible divergences in
glucose concentration, b-cell number, and/or in vivo neogenesis
that may occur in studies using islets of subjects with hypergly-
cemia versus euglycemia. Thus, the simultaneous augmentation of
cell death and deceleration in cell proliferation are indeed a
consequence of PIHO disorder in this dysfunctional b-cell model.
This demonstration aids understanding of discrepancies in the
examined in vivo b-cell death in Akita mice [33,52] and reveals the
decelerated proliferation that would contribute to progressive loss
of b-cells in Akita mice. Although unfolded protein responses, such
as the Chop-10/gadd153 pathway known to be implicated in the
increased death of Ins2
+/Akita b-cells [52], are activated by PIHO
disorders, the mechanisms underlying the decelerated replication
remain unclear. In diabetes of type 1 and type 2, the increase in b-
cell apoptosis is known to contribute to b-cell depletion as the
disease develops [2,5,10], but it remains unclear whether b-cell
proliferative responses contribute to the increase [10]. A recent
study shows decreased b-cell proliferation with type 2 diabetes in
obese donors [45]. The decelerated replication of b-cells as a
consequence of PIHO disorders may be associated with a deficit in
b-cell mass in diabetes.
In summary, our findings provide the first clear demonstration
that perturbation of PIHO produces severe oxidative stress and
impairs GSIS and b-cell survival. In model Ins2
+/Akita b-cells/islets,
the anomalies we characterize represent the extensive defects that
arise from PIHO disorder and are known to be associated with
diabetes, including insulin deficiency, GSIS impairment, organelle
structure abnormality, oxidative and ER stress, decelerated cell
proliferation, increased cell death, disproportionally high proinsu-
lin/insulin ratio [32], and insulin resistance [53]. However,
disorders in PIHO occur in several unique diabetic models with
mono/poly-genetic defects that represent the primary forms of
diabetes in humans (unpublished data). PIHO is susceptible to
genetic and environmental influences, and its susceptibility is
linked to the inherent low relative folding rate versus plentiful
amount of insulin precursor manufactured in b-cells [23].
Accordingly, PIHO disorder would contribute to b-cell defects
in diabetes of general forms in addition to monogenic diabetes
with heterogeneous mutations in the insulin gene. Unquestionably,
the properties and extent of PIHO disorder, duration of
development of b-cell failure, and symptoms of diabetes may vary
greatly because of differences in inducers. An example is the
diverse symptoms of patients with heterogeneous mutations in the
same preproinsulin molecule [26–30]. Thus, the molecular
mechanisms underlying the maintenance, perturbation, and
consequences of PIHO deserve further study to develop
approaches aimed at preserving or restoring b-cell function in
diabetes.
Materials and Methods
Ethics statement
All animal and tissue sample experiments have been approved
by the Institutional Animal Care and Use Committee of The Ohio
State University (protocol number 2007A0040 and 2010A0024)
and were performed in accordance with the guidelines of the
National Institutes of Health and The Ohio State University.
Reagents, cell lines, and mice
In this study, we applied antibodies against rat C-peptide II
(Millipore, Bedford, MA, USA), insulin (Dako North America,
Inc.), TXNIP (Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA), tubulin (Sigma-Aldrich, St. Louis, Mi, USA), and tyrosine-
nitrated proteins (kindly provided by Dr. J.A. Hinson, University
of Arkansas for Medical Sciences, Little Rock, AR, USA) [54].
Second antibodies were purchased from Jackson ImmunoRe-
search Laboratories (West Grove, PA, USA). We obtained
proinsulin, dithiothreitol, collagenase, and 59-bromo-29-deoxyur-
idine (BrdU) from Sigma-Aldrich; TRIZOL and reverse tran-
scription (RT)-PCR reagents, H2DCFDA, culture media from
Invitrogen (Carlsbad, CA, USA); 49,6-diamidino-2-phenylindole
(DAPI) and protease inhibitor cocktail from Roche Applied
Science (Indianapolis, IN, USA). We obtained Immobilon-P
SQ
membrane from Millipore, and [
35S]-methionine (3.7610
13 Bq/
mmol) from Perkin Elmer Life Science (Waltham, MA, USA). The
Ins2
+/+ and Ins2
+/Akita b-cell lines were kindly provided by Drs. H.
Kubota and K. Nagata (Kyoto University, Kyoto, Japan). The
C57BL/6J and Ins2
+/Akita mice were purchased from The Jackson
Laboratory (Bar Harbor, Maine, USA).
Islet preparation and cell culture
Islet isolation and culture of islets in 10% FCS/RPMI 1640
medium (containing 11 mmol/L glucose) and established Ins2
+/+
or Ins2
+/Akita b-cells in the customary10% FCS/DMEM medium
(containing 25.5 mmol/L glucose if no noted specifically) were
described previously [17,30–32].
Semi-quantitative PCR
The procedure was described previously [31]. Briefly, RNAs of
the established Ins2
+/+ and Ins2
+/Akita b-cells were extracted by
using TRIZOL reagent for reverse transcription. Semi-quantita-
tive examination of insulin transcripts were performed by PCR
amplification with a set of primers derived from the identical
region of insulin 1 and insulin 2 genes. The sequence of primers
for insulin is 59-GCTCTCTACCTGGTGTGTGG-39 and 59-
GTTTTATTCATTGCAGAGGG-39 and for b-actin is 59-
CGTAAAGACCTCTATGCCAA-39 and 59-AGCCATGC-
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was 257 bp for insulin1, 263 bp for insulin 2, and 349 bp for b-
actin.
Metabolic-labeling and autoradiography
Ins2
+/+ and Ins2
+/Akita b-cells were cultured in the customary
10% FCS/DMEM medium for 48 h and then labeled with [
35S]-
methionine for 30 min as described previously [17,23,31]. Cellular
proteins were then subjected to immunoprecipitation with C-
peptide antisera. Immunoprecipitates were resolved by reduced
tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) for autoradiography as described previously [23,31].
Immunoblotting
Whole-cell, nucleus, or secreted proteins were resolved by SDS-
PAGE for immunoblot analyses as described previously [23,31]. In
this study, reduced SDS-PAGE was applied (except for the non-
reduced SDS-PAGE used only in Fig. 2B). For collection of cell
nucleus fraction, cells were homogenized in a homogenate buffer
in a glass, hand driven tissue homogenizer and then subjected to
centrifugation with a centrifugal force of 600 g for 15 min at 4uC
as described previously [17].
Histological studies
Ins2
+/+ and Ins2
+/Akita b-cells were cultured in the customary
10% FCS/DMEM medium for 48 h and their light microscopic
images were then examined with an Axiovert 200 microscope
(Carl Zeiss, Oberkochen, Germany). Fluorescent staining with
DAPI and antibodies against to tyrosine-nitrated proteins (1:500)
[54] and C-peptide (1:500) on pancreatic sections (5 mm thickness)
was performed as described previously [17,31]. Fluorescent images
were examined under Axiovert 200 microscope with Axiovision
software.
Electron microscopic examination approaches were described
previously [17,31]. Briefly, cells were fixed with 2% glutaraldehyde
and paraformaldehyde in 100 mmol/L sodium cacodylate buffer
(pH 7.4) for 2 h, incubated in 1% osmium tetroxide in 100 mmol/
L sodium cacodylate buffer for 1 h, stained with 1% uranyl acetate
in maleate buffer (pH 5.1) for 1 h, and then dehydrated through a
graded ethanol series. After infiltration and polymerization in a
propylene oxide and spurr resin mixture, the embedded samples
were cut with a Reichert Ultracut-E microtome (Reichert-Jung,
Vienna, Austria), and stained with uranyl acetate and lead citrate.
Images were observed with a FEI Tecnai F30 electron microscope
at accelerating potential of 300 kV. The quantitative evaluation of
photographs from 20 b-cells each group was performed as
described previously [42].
Examination of reactive oxygen species
After 48 h culture in the customary 10% FCS/DMEM
medium, Ins2
+/+ and Ins2
+/Akita b-cells were treated with
5 mmol/L H2DCFDA for 10 min according to the Instructions
(Invitrogen). H2DCFDA fluorescent images were examined under
Axiovert 200 microscope with Axiovision software.
Examination of dead and alive cell numbers and cell
proliferation
Ins2
+/Akita and Ins2
+/+b-cells with same passage numbers were
seeded on 6-well/plates (5.0610
5 cells/well) and cultured in the
customary 10% FCS/DMEM medium. At 24, 48, 72, and 96 h
after cells were seeded, detached cells (in media) and attached cells
(on plates) were harvested. Dead or alive cells were determined by
trypan blue (Invitrogen) staining method according to the
manufacturer’s instructions and then counted in haemocytometer
chambers. For measurement of cell proliferation by BrdU labeling
assay, Ins2
+/Akita and Ins2
+/+b-cells after seeded for one day were
incubated with 10 mmol/L BrdU for 24 h. Cells were fixed and
subjected to staining with DAPI and anti-BrdU (1:200, Sigma-
Aldrich) antibody as described previously [17,31]. Proliferative
index is expressed as a percentage of BrdU- and DAPI-positive
cells over total DAPI -positive cells analyzed under Axiovert 200
microscope with Axiovision software.
Statistical analysis
Densitometry of fluorescent images was quantified by NIH
ImageJ software. Data are shown as the mean or the mean 6 SD.
Statistical significance (*P,0.05; **P,0.01) was assessed by
Student’s t-test (two-tailed). All experiments were performed at
least three independent times.
Supplemental Data
Supplemental Data, including 2 figures and 1 table, can be
found with this article on the PLoS ONE web site.
Supporting Information
Figure S1 Levels of secreted insulin and proinsulin that
were immunopurified by insulin antisera or mixed
antisera to insulin and C-peptide. (A) Proinsulin and insulin
secreted by Ins2
+/+ b-cells during a 120-minute customary glucose
(25.5 mmol/L) culture course were immunopurified with insulin
(Ins) antisera or mixed antisera to insulin and C-peptide (Cp),
resolved with proinsulin marker (Sigma) by 16.5% tricine non-
reduced SDS-PAGE, and examined by insulin immunoblot. (B)
The relative levels of proinsulin or insulin immunoprecipitated by
Ins or Ins combined with Cp antisera shown in (A). Marker,
proinsulin marker (Sigma); IP, immunoprecipitation; n=3; *,
P,0.05.
(TIF)
Figure S2 Decelerated proliferation of Ins2
+/Akita b-
cells. Ins2
+/Akita and Ins2
+/+b-cells after one day culture were
then incubated with BrdU (10 mmol/L) in the customary culture
medium for 24 h. Proliferative index was determined as the
number of BrdU- and DAPI-positive cells over total DAPI-positive
cells, and data are presented as the percentage of BrdU- and
DAPI-positive cells in the total DAPI-positive cells. n=3; **,
P,0.005.
(TIF)
Table S1 Morphometric analysis of Ins2
+/+ versus
Ins2
+/Akita b-cells.
(PDF)
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